Old Dogs Can Learn New Tricks: Is Outpatient Remdesivir a Game Changer against Omicron?
Evidence Based Medicine presented by InpharmD™
Release Date: 01/20/2022
Ketamine for Sickle Cell Disease
Evidence Based Medicine presented by InpharmD™
InpharmD's EBM podcast focuses on commonly asked drug information questions and the associated literature. This episode focuses on the use of ketamine for Sickle Cell Disease.
info_outline
Tirzepatide for Sleep Apnea
Evidence Based Medicine presented by InpharmD™
InpharmD's EBM podcast focuses on commonly asked drug information (DI) questions and the associated literature. Everyday, our queue gets tons of questions asked by health care providers all around the country. For this episode, we assess tirzepatide for obstructive sleep apnea and analyze the SURMOUNT-OSA clinical trials.
info_outline
Excoriation Disorder
Evidence Based Medicine presented by InpharmD™
InpharmD's EBM podcast focuses on commonly asked drug information (DI) questions and the associated literature. Everyday, our queue gets tons of questions asked by health care providers all around the country. For this episode, we assess treatment options for excoriation disorder.
info_outline
Phenytoin for Tacrolimus Toxicity
Evidence Based Medicine presented by InpharmD™
InpharmD's EBM podcast focuses on commonly asked DI questions. Every day, our queue gets tons of new questions asked from providers all around the country. Today's podcast focuses on the use of phenytoin to treat tacrolimus toxicity.
info_outline
Atypical Antipsychotics and QT–prolongation
Evidence Based Medicine presented by InpharmD™
InpharmD's EBM podcast focuses on commonly asked drug information questions. Every day, our queue gets tons of new questions asked from providers all around the country. One question that’s been garnering a lot of views from our users right now is which atypical antipsychotics are associated with the lowest and highest risk of QT prolongation.
info_outline
Apixaban in Peripheral Artery Disease
Evidence Based Medicine presented by InpharmD™
Join InpharmD as we discuss the role of apixaban in peripheral artery disease.
info_outline
Safety and Efficacy of RSV Vaccines
Evidence Based Medicine presented by InpharmD™
Join InpharmD as we discuss the safety and efficacy of two FDA-approved RSV vaccines, Arexvy and Abrysvo.
info_outline
Safety and Efficacy of Rezafungin
Evidence Based Medicine presented by InpharmD™
Join us as we discuss the data surrounding newly approved antifungal agent, rezafungin. Interested in learning more? Join our CE on rezafungin on July 27th at 12:00 PM EST - open to all pharmacists!
info_outline
Perioperative Duloxetine During Orthopedic Surgery for Pain Reduction
Evidence Based Medicine presented by InpharmD™
Join InpharmD as we discuss the data on perioperative duloxetine (Cymbalta) during orthopedic surgery for pain reduction. Interested in the full data response? !
info_outline
Lecanemab in the treatment of Alzheimer’s Dementia
Evidence Based Medicine presented by InpharmD™
Every month, InpharmD creates a continuing-education (CE) class on the most commonly asked drug information question and the related evidence. Our podcast offers a sneak peak into our CE as we briefly discuss the topic. Episode-2 looks at the safety and efficacy of lecanemab in the treatment of Alzheimer’s dementia.
info_outline